
Hyglim M 2mg/500mg Tablet SR
Marketer
Sunniva Life Science
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Overview Hyglim M 2mg/500mg Tablet SR
Diabetol Duo 2mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabetol Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as premature discontinuation without medical consultation risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is just one component of a comprehensive diabetes management plan that incorporates a balanced diet, regular physical activity, and weight management as recommended by your doctor. Lifestyle modifications are integral to diabetes control. The most prevalent adverse reaction is hypoglycemia (low blood sugar). Learn to identify symptoms like sweating, dizziness, headaches, and tremors, and know how to treat them promptly. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.
Uses of Hyglim M 2mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Hyglim M 2mg/500mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Hyglim M 2mg/500mg Sustained-Release Tablets should be administered with food.
Common Side effects of Hyglim M 2mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Hyglim M 2mg/500mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Hyglim M 2mg/500mg Sustained-Release tablets should be taken with meals.
How Hyglim M 2mg/500mg Tablet SR works:
Hyglim M SR tablets (2mg/500mg) combine glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol consumption while taking Hyglim M 2mg/500mg SR tablets.
PregnancyCONSULT YOUR DOCTOR
The use of Hyglim M 2mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingUNSAFE
Extended-release Hyglim M 2mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.
DrivingCAUTION
Impaired driving is possible with abnormally high or low blood glucose levels. Refrain from driving if you experience such symptoms.
KidneyCAUTION
Patients with kidney impairment should use Hyglim M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Hyglim M 2mg/500mg SR tablet use. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Hyglim M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate liver disease, a low initial dose of Hyglim M 2mg/500mg SR tablets is typically recommended; however, its use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Hyglim M 2mg/500mg Tablet SR :
Should you forget to take your Hyglim M 2mg/500mg Tablet SR, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid doubling the prescribed dosage.
Facts to Know About Hyglim M 2mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |
